colorectal cancer screening decision aid (Robeson Health Care Corporation)
Structured Review

Colorectal Cancer Screening Decision Aid, supplied by Robeson Health Care Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/based+adaptive+model+predictive+controller/pmc08746463-19-0-14?v=Robeson+Health+Care+Corporation
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Molecular Pathogenesis of Colorectal Cancer with an Emphasis on Recent Advances in Biomarkers, as Well as Nanotechnology-Based Diagnostic and Therapeutic Approaches"
Article Title: Molecular Pathogenesis of Colorectal Cancer with an Emphasis on Recent Advances in Biomarkers, as Well as Nanotechnology-Based Diagnostic and Therapeutic Approaches
Journal: Nanomaterials
doi: 10.3390/nano12010169
Figure Legend Snippet: Involvement of MSI, CpG, and CIMP in the progression of CRC. ( A ) Every age groups are susceptible to malignancy, and progression of colorectal cancer shows after the occurrence of metastasis; ( B ) In the case of CIN, various molecular pathways play crucial roles such as Wnt, KRAS, TP53, and EMAST and forms CRC progression. While MSI-H shows progression via hMLH1 and BRAF. Whereas, CIMP is interconnected with KRAS mutation and causes cytogenetic to normal cells.
Techniques Used: Mutagenesis
Figure Legend Snippet: Epidemiology of colorectal cancer.
Techniques Used:
Figure Legend Snippet: Diagnostic/materialistic tool for the treatment of colorectal cancer.
Techniques Used: Diagnostic Assay
Figure Legend Snippet: Illustration of completed and ongoing clinical trials evidence for CRC.
Techniques Used: Clinical Proteomics, Comparison, Positron Emission Tomography
